logo

Allergan Inc. (AGN)



Trade AGN now with
  Date
  Headline
3/18/2019 7:31:23 AM Allergan Announces FDA Approval Of AVYCAZ For Pediatric Patients
3/14/2019 7:33:41 AM Allergan To Present New Data Including Late-breaking Abstract For Bimatoprost SR At AGS Annual Meeting
3/11/2019 7:31:58 AM Allergan Announces FDA Acceptance Of NDA For Ubrogepant For Acute Treatment Of Migraine
3/7/2019 8:04:10 AM Allergan Says FDA Accepts Supplemental Biologics License Applications For BOTOX
3/1/2019 7:33:29 AM Allergan Presents Data From Seven Abstracts At 2019 American Academy Of Dermatology In Washington D.C.
2/19/2019 7:05:35 AM Allergan Names Robert Hugin To Its Board, Effective Immediately
2/5/2019 9:16:50 AM Appaloosa Sends Letter To Allergan Board Urging Separation Of Chairman And CEO Roles
1/29/2019 7:15:48 AM Allergan Inc. (AGN) Announces $2.0 Bln Stock Buyback
1/29/2019 7:02:41 AM Allergan Q4 GAAP Loss Per Share $12.83; Non-GAAP Performance Net Income Per Share $4.29
1/25/2019 7:36:11 AM Allergan Inc. (AGN) Declares $ 0.74 Dividend for Q1 19, Record Date 2/15/2019